José Carlos Nóbrega Júnior

Prof. Dr. José Carlos Nóbrega Júnior

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Nature and Science of Sleep
Verified
Journal Article
Open access
PDF file
JJJosé Carlos Nóbrega Júnior
José Carlos Nóbrega Júnior
AAArmèle Dornelas de Andrade
Armèle Dornelas de Andrade
EAErika Alves Marinho de Andrade
Erika Alves Marinho de Andrade
MAMaria Do Amparo Andrade
Maria Do Amparo Andrade
ARAlice Santana Valadares Ribeiro
Alice Santana Valadares Ribeiro
ALAnna Myrna Jaguaribe de Lima
Anna Myrna Jaguaribe de Lima
Purpose: Exercise programs have been considered as an adjuvant treatment in obstructive sleep apnea (OSA). However, few studies have focused on the effects of the inspiratory muscle training (IMT) in reducing the severity and the symptoms of OSA. Patients and Methods: A randomized controlled trial was conducted and approved by the local Ethics Committee. All subjects signed the informed consent form and were randomized into 2 groups: a) IMT group (n = 8), 8 weeks of IMT with 75% of maximal inspiratory pressure (MIP) and b) placebo group (n = 8): subjects performed IMT without load. Results: IMT group showed reduction in the apnea–hypopnea index (AHI) (p = 0.01), in the Berlin questionnaire score (p = 0.001) and an increase in inspiratory muscle strength (p = 0.018). IMT group demonstrated a reduction in the AHI (31.7 ± 15.9 events/h vs 29.9 ± 15.8 events/h; p < 0.001), in the Berlin questionnaire scores (2.6 ± 0.5 vs 1.2 ± 0.5; p = 0.016), Pittsburgh Sleep Quality Index (PSQI) score (7.2 ± 3.6 vs 3.7 ± 1.3; p = 0.008), in the Epworth Sleepiness Scale (ESS) (12.5 ± 4.0 vs 7.7 ± 3.0; p = 0.008) and increase in MIP (83.6 ± 26.5 cmH2O and 127.9 ± 32.5 cmH2O; p = 0.010). Conclusion: The IMT promotes discrete changes in the AHI and improves sleep quality and excessive daytime sleepiness in OSA. Moreover, IMT is a cheap, useful and simple home-based training program and can be considered as an adjunct therapy for OSA patients.

19 January 2026 in COVID
Verified
Journal Article
Open access
PDF file
JJJosé Carlos Nóbrega Júnior
José Carlos Nóbrega Júnior
DBDaniella Brandão
Daniella Brandão
DXDaiara Xavier
Daiara Xavier
RSRoberta Cristiane Torres da Silva
Roberta Cristiane Torres da Silva
SBSimone Soares Brandão
Simone Soares Brandão
AAArmele Dornelas de Andrade
Armele Dornelas de Andrade
Background and Purpose: Post-COVID-19 syndrome significantly impacts respiratory function and quality of life. Inspiratory muscle training (IMT) has been proposed as a potential intervention to improve respiratory muscle strength and overall recovery. This study aimed to evaluate the effects of IMT on respiratory muscle performance, lung function, functional capacity, sleep quality, and quality of life in individuals with post-COVID-19 syndrome. Methods: Nineteen individuals with post-COVID-19 syndrome were randomized into an IMT group (N = 10) or a sham group (N = 9). The IMT group performed eight weeks of training at 50% of maximal inspiratory pressure (MIP), while the sham group used a non-load device. Outcomes included MIP (cm H2O), functional capacity (6MWT), lung function (spirometry), sleep quality (PSQI), and quality of life (SF-36). Results: The IMT group showed significant improvements in MIP (125.50 ± 22.50 vs. 93.67 ± 20.87 cm H2O; p = 0.036; Cohen’s d = 0.50), PSQI (4.40 ± 2.50 vs. 9.00 ± 2.80; p = 0.011; Cohen’s d = 0.60), and SF-36 (p = 0.030). The IMT group also increased 6MWT distance by 58.36 ± 25.10 m. Conclusions: IMT significantly improved respiratory muscle strength, sleep quality, and quality of life in post-COVID-19 syndrome. These findings suggest that IMT may be an effective intervention, warranting further studies to confirm long-term benefits.

4 June 2021 in Revista Brasileira de Fisiologia do Exercício
Verified
Journal Article
Open access
PDF file
JJJosé Carlos Nóbrega Júnior
José Carlos Nóbrega Júnior
AAArmele Dornelas de Andrade
Armele Dornelas de Andrade
ASAdí­lIa Karoline Ferreira Souza
Adí­lIa Karoline Ferreira Souza
MAMaria Inês Remí­gIo de Aguiar
Maria Inês Remí­gIo de Aguiar
RPRodrigoPinto Pedrosa
RodrigoPinto Pedrosa
ALAnna Myrna Jaguaribe de Lima
Anna Myrna Jaguaribe de Lima
Objetivo: O objetivo deste trabalho foi testar a hipótese que o teste de AVD-Glittre (TGlittre) tem validade concorrente e reprodutibilidade intra-avaliador em indivíduos com apneia obstrutiva do sono (AOS). Métodos: Foram avaliados 22 indivíduos, de ambos os sexos, com diagnóstico AOS. O TGlittre e o teste de esforço cardiopulmonar (TECP) foram realizados em dois dias diferentes, duas vezes cada, e a ordem era determinada por randomização. Resultados: A FC máxima (FCmáx) obtida no TGlittre foi de 130,6 ± 13,3 bpm e o tempo total para a realização do teste foi de 3,4 ± 0,5 min. Sobre as varáveis analisadas no TECP, foram obtidos os seguintes valores: consumo máximo de oxigênio (VO2máx) = 2,4 ± 5,3 ml/kg/min, VO2 no primeiro limiar = 19,4 ± 3,9 ml/kg/min, FCmáx = 161,3 ± 15,2 bpm e o tempo total de realização do teste foi de 8,3 ± 1,6 min. Uma correlação negativa moderada foi verificada entre o tempo de realização do TGlittre e VO2max (r = -0,424; p = 0,049). Na análise da confiabilidade teste-reteste do tempo total de realização do TGlittre, foi observada uma excelente concordância e consistência entre as medidas (coeficiente de correlação intraclasse (CCI) = 0,865; IC95%: 0,379-0,965 (p ≤ 0,0001). Conclusão: O teste de TGlittre é válido e reprodutível na AOS. Além disso, é um teste de intensidade submáxima, fácil aplicação e baixo custo, que pode ser utilizado em larga escala.

15 July 2026 in Complementary Therapies in Medicine
Verified
Journal Article
Open access
ABAlessandra Boaviagem
Alessandra Boaviagem
JJJosé Carlos Nóbrega Júnior
José Carlos Nóbrega Júnior
RSRita de Cassia Barros da Silva
Rita de Cassia Barros da Silva
ALAndréa Lemos
Andréa Lemos
Photobiomodulation with low-level laser therapy has been investigated as an adjunctive strategy for postoperative pain and wound healing after cesarean section, but the available trials use heterogeneous protocols and outcomes. To evaluate the effects of low-level laser therapy, compared with sham treatment or usual care, on postoperative pain, wound healing, analgesic use, global perception of change, and adverse-event reporting after cesarean section. This systematic review followed a protocol registered in PROSPERO (CRD420251077815) and was conducted and reported according to PRISMA 2020 guidance. Electronic databases were searched from inception through June 4, 2025, without language or date restrictions. Randomized and quasi-randomized trials were eligible, although all included studies were randomized controlled trials. Four randomized controlled trials involving 473 women were included (Poursalehan et al., 2018, n = 80; de Holanda Araújo et al., 2019, n = 88; Saffarieh et al., 2020, n = 65; Kahkhaie et al., 2023, n = 240). A random-effects meta-analysis was considered for pain outcomes but was not performed because of substantial clinical and methodological heterogeneity in laser parameters, comparators, follow-up times, outcome scales, and reporting of effect estimates. Individual studies reported reductions in pain scores or analgesic use in some comparisons, but findings were not sufficiently consistent or reproducible across protocols. Wound-healing outcomes were reported by a limited subset of studies using different indicators. The certainty of evidence was rated low to very low, mainly because of risk of bias, inconsistency, imprecision, and indirectness. The available evidence is insufficient to support routine clinical use of low-level laser therapy after cesarean section. Photobiomodulation should be considered an experimental or insufficiently validated adjunct in this context until adequately designed trials establish standardized dosimetry, clinically meaningful outcomes, and reproducible effects.

23 September 2025 in International Journal of Imaging Systems and Technology
Verified
Journal Article
Open access
JJJosé Carlos Nóbrega Júnior
José Carlos Nóbrega Júnior
SBSimone Soares Brandão
Simone Soares Brandão
James B. FinkJames B. Fink
James B. Fink
DXDaiara Xavier
Daiara Xavier
RSRoberta Cristiane Torres da Silva
Roberta Cristiane Torres da Silva
AAArmele Dornelas de Andrade
Armele Dornelas de Andrade
Pulmonary dysfunction is a common sequel of COVID‐19, with long‐term effects on lung function even after recovery. Traditional imaging methods like computed tomography (CT) and X‐ray often fail to detect subtle functional impairments. In contrast, ventilation and perfusion scintigraphy (V/Q scintigraphy) provide a sensitive assessment of regional ventilatory and perfusion abnormalities, revealing functional changes missed by anatomical imaging. To compare the regional pulmonary distribution of radiopharmaceuticals in symptomatic and asymptomatic post‐COVID‐19 individuals. A cross‐sectional study was conducted with 33 post‐COVID‐19 individuals, categorized into asymptomatic (n = 10) and symptomatic groups (n = 23), classified according to symptom severity. Ventilation and perfusion scintigraphy were performed using technetium‐99m radiopharmaceuticals (99mTc‐DTPA for ventilation and 99mTc‐MAA for perfusion). Pulmonary radiopharmaceutical activity was quantified using Regions of Interest (ROIs) in central and peripheral zones and upper, middle, and lower regions. Symptomatic patients showed significantly lower radiopharmaceutical activity in all pulmonary regions compared to asymptomatic participants (p < 0.05). Perfusion analysis revealed significantly higher total lung radiopharmaceutical counts in asymptomatic individuals (Median [IQR]: 1046.94 [447.41] Kct) compared to symptomatic individuals (765.66 [269.94] Kct, p = 0.002). No significant differences were found in the left lung regions. The total pulmonary count during the ventilation phase progressively decreases as disease severity increases. The comparison between the extremes (asymptomatic vs. severe) reveals a nearly 50% reduction in pulmonary counts. Significant differences in pulmonary radiopharmaceutical activity were observed between groups, with reduced ventilatory and perfusion functionality in symptomatic patients. These findings underscore the importance of advanced techniques for monitoring and individualized rehabilitation of post‐COVID‐19 patients.

14 November 2021 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
PMPablo Rafael De Negreiros Marques
Pablo Rafael De Negreiros Marques
TATayanna Alves de Almeida
Tayanna Alves de Almeida
MRMateus Porfirio Rodrigues
Mateus Porfirio Rodrigues
ILIngrid Larissa da Silva Laurindo
Ingrid Larissa da Silva Laurindo
EMEudson José Santos Do Monte
Eudson José Santos Do Monte
JJJosé Carlos Nóbrega Júnior
José Carlos Nóbrega Júnior
Objetivo: Descrever os principais pontos de acupuntura utilizados no tratamento da dismenorreia primária. Método: Trata-se de uma revisão de literatura narrativa, onde foram utilizados ensaios clínicos, com os seguintes descritores: “Acupuncture”, “Acupuncture Points”, “Chinese Medicine” e “Primary Dysmenorrhea”. As buscas ocorreram nas bases de dados da SciELO, PubMed, LILACS, PEDro, Portal de Periódicos CAPES, ScienceDirect e Cochrane no período de 2011 a 2021, com artigos selecionados entre janeiro 2016 a dezembro 2021, em qualquer idioma, que apresentassem em seu objetivo de pesquisa descrever os principais pontos de acupuntura utilizados no tratamento da dismenorreia primária. Foram considerados inábeis artigos duplicados e pagos, de revisão, meta-análises e mulheres que apresentassem patologias associadas. Resultados: Foram identificados 334 artigos, dos quais 5 preencheram os critérios de inclusão, abrangendo um total de 348 pacientes com diagnostico de dismenorreia primaria. O uso terapêutico do baço 6 (BP-6) foi avaliado em três das cincos publicações selecionadas, atendendo a diversos objetivos. O desfecho primário mais avaliado foi a intensidade da dor menstrual. Conclusão: Conclui-se que a acupuntura pode ser usada como um método eficaz e seguro no tratamento em mulheres com dismenorreia primaria.